Macquarie Group LTD Ligand Pharmaceuticals Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 887,275 shares of LGND stock, worth $102 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

887,275

Previous 966,552 8.2%

Holding current value

$102 Million

Previous $81.4 Million 9.13%

% of portfolio

0.1%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $6.56 Million - $8.73 Million	-79,277 Reduced 8.2%	887,275 $88.9 Million
Q2 2024 Aug 09, 2024	SELL	$68.53 - $87.91 $4.57 Million - $5.86 Million	-66,629 Reduced 6.45%	966,552 $81.4 Million
Q1 2024 May 14, 2024	BUY	$68.64 - $89.2 $3.15 Million - $4.09 Million	45,827 Added 4.64%	1,033,181 $75.5 Million
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $221,280 - $324,220	-4,464 Reduced 0.45%	987,354 $70.5 Million
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $9.1 Million - $11.2 Million	154,648 Added 18.47%	991,818 $59.4 Million
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $1.33 Million - $1.52 Million	19,187 Added 2.35%	837,170 $60.4 Million
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $1.14 Million - $1.34 Million	17,387 Added 2.17%	817,983 $60.2 Million
Q4 2022 Feb 21, 2023	BUY	$61.72 - $96.74 $430,497 - $674,761	6,975 Added 0.88%	800,596 $53.5 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $96 - $1.04 Million	9,697 Added 1.24%	793,621 $68.3 Million
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $1.88 Million - $2.95 Million	25,183 Added 3.32%	783,924 $69.9 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $12.7 Million - $20.3 Million	133,772 Added 21.4%	758,741 $85.4 Million
Q4 2021 Feb 11, 2022	SELL	$127.69 - $165.85 $2.53 Million - $3.29 Million	-19,809 Reduced 3.07%	624,969 $96.5 Million
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $5.23 Million - $7.39 Million	51,080 Added 8.6%	644,778 $89.8 Million
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $12.4 Million - $17 Million	109,340 Added 22.57%	593,698 $77.9 Million
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $40.8 Million - $88.6 Million	-410,320 Reduced 45.86%	484,358 $73.8 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $11.2 Million - $14.7 Million	138,545 Added 18.32%	894,678 $89 Million
Q3 2020 Nov 13, 2020	BUY	$89.56 - $126.72 $1.26 Million - $1.78 Million	14,080 Added 1.9%	756,133 $72.1 Million
Q2 2020 Aug 11, 2020	BUY	$68.28 - $123.65 $3.34 Million - $6.05 Million	48,968 Added 7.07%	742,053 $83 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $3.41 Million - $5.81 Million	53,820 Added 8.42%	693,085 $50.4 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $7.69 Million - $9.01 Million	79,300 Added 14.16%	639,265 $66.7 Million
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $2.94 Million - $4.1 Million	34,128 Added 6.49%	559,965 $55.7 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $3.76 Million - $4.53 Million	35,055 Added 7.14%	525,837 $60 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $5.42 Million - $7.29 Million	51,195 Added 11.65%	490,782 $61.7 Million
Q4 2018 Feb 15, 2019	BUY	$128.36 - $272.13 $8.43 Million - $17.9 Million	65,712 Added 17.58%	439,587 $59.7 Million
Q3 2018 Nov 15, 2018	SELL	$211.18 - $274.49 $4.91 Million - $6.38 Million	-23,238 Reduced 5.85%	373,875 $103 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $1.5 Million - $2.07 Million	9,970 Added 2.58%	397,113 $82.3 Million
Q1 2018 May 11, 2018	BUY	$138.63 - $182.62 $2.55 Million - $3.36 Million	18,420 Added 5.0%	387,143 $63.9 Million
Q4 2017 Feb 15, 2018	SELL	$128.36 - $147.04 $12.1 Million - $13.9 Million	-94,312 Reduced 20.37%	368,723 $50.5 Million
Q3 2017 Nov 08, 2017	BUY	$120.91 - $137.94 $56 Million - $63.9 Million	463,035	463,035 $63 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Ligand Pharmaceuticals Inc Transaction History